Reorienting our view of particle-based adjuvants for subunit vaccines.
Departments of Chemical Engineering, Bioengineering, and Immunology, and The McGowan Institute for Regenerative Medicine, University of Pittsburgh, Pittsburgh, PA 15261, USA. srlittle@pitt.edu.
Steven R
SR
Little
D000953:Antigens, Protozoan / Q000276:immunology*; D001402:B-Lymphocytes / Q000276:immunology*; D017780:Malaria Vaccines / Q000276:immunology*; D053758:Nanoparticles / Q000008:administration & dosage*; D010966:Plasmodium vivax / Q000276:immunology*; D015800:Protozoan Proteins / Q000276:immunology*; D011994:Recombinant Proteins / Q000276:immunology*; D006377:T-Lymphocytes, Helper-Inducer / Q000276:immunology*
D000953:Antigens, Protozoan; D017780:Malaria Vaccines; D015800:Protozoan Proteins; D011994:Recombinant Proteins; C041595:circumsporozoite protein, Protozoan